300639.SZ Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 apr 2024 @ 09:04):

Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes...

Stats
Dagens volum	7.55M
Gjennomsnittsvolum	7.15M
Markedsverdi	4.03B
EPS	CNY0 ( 2023-10-25 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	10.10
ATR14	CNY0.0110 (0.18%)

Volum Korrelasjon

Lang: 0.00 (neutral)

Kort: 0.00 (neutral)

Signal:(40.853) Neutral

Guangdong Hybribio Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Guangdong Hybribio Korrelasjon - Valuta/Råvare

0.37
( neutral )

0.22
( neutral )

0.00
( neutral )

-0.15
( neutral )

Guangdong Hybribio Økonomi

Annual	2022
Omsetning:	CNY5.60B
Bruttogevinst:	CNY3.88B (69.36 %)
EPS:	CNY2.65

FY	2022
Omsetning:	CNY5.60B
Bruttogevinst:	CNY3.88B (69.36 %)
EPS:	CNY2.65

FY	2021
Omsetning:	CNY2.67B
Bruttogevinst:	CNY1.81B (67.63 %)
EPS:	CNY3.12

FY	2020
Omsetning:	CNY1.35B
Bruttogevinst:	CNY993.74M (73.37 %)
EPS:	CNY1.327

Financial Reports:

No articles found.

Guangdong Hybribio

Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes. It provides in-vitro diagnostic kits for human papilloma virus, sexually transmitted diseases (STD), thalassemia, and prenatal and postnatal. The company also offers STD real time PCR kits; hepatitis B virus real-time PCR kits and thalassemia genoarray diagnostic kits; hearing loss susceptibility genoarray diagnostic kits; COVID-19 real-time PCR kits; and devices/instruments, including automated nucleic acid extraction, automatic medical PCR analysis, flow-through hybridization, auto DNA extraction, and fluorescent quantitative detection systems, as well as after-sales technical service support. Its products are used in the fields of national screening, clinical, and research purposes. The company operates in the Asia Pacific, the South East Asia, the Middle East, Europe, Africa, and South America. Guangdong Hybribio Biotech Co.,Ltd. was founded in 2003 and is based in Sheung Wan, Hong Kong.